Literature DB >> 18456653

Enhanced RNA polymerase III-dependent transcription is required for oncogenic transformation.

Sandra A S Johnson1, Louis Dubeau, Deborah L Johnson.   

Abstract

RNA polymerase (pol) III transcription, responsible for the synthesis of various stable RNAs, including 5 S rRNAs and tRNAs, is regulated by oncogenic proteins and tumor suppressors. Although it is well established that RNA pol III-dependent transcription is deregulated in transformed cells and malignant tumors, it has not been determined whether this represents a cause or consequence of these processes. We show that Rat1a fibroblasts undergoing oncogenic transformation by the TATA-binding protein or c-Myc display enhanced RNA pol III transcription. Decreased expression of the RNA pol III-specific transcription factor Brf1 prevented this increase in RNA pol III transcription. Although the overall proliferation rates of these cells remained unchanged, the ability of cells to grow in an anchorage-independent manner and form tumors in mice was markedly reduced. Although overexpression of Brf1 modestly stimulated RNA pol III transcription, expression of a phosphomimic, Brf1-T145D, more significantly induced transcription. However, these increases in transcription were not sufficient to promote cellular transformation. Together, these results demonstrate that enhanced RNA pol III transcription is essential for anchorage-independent growth and tumorigenesis and that these events can be uncoupled from effects on anchorage-dependent proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18456653      PMCID: PMC2443659          DOI: 10.1074/jbc.M802872200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Transcriptional activation of RNA polymerase III-dependent genes by the human T-cell leukemia virus type 1 tax protein.

Authors:  J M Gottesfeld; D L Johnson; J K Nyborg
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  Regulation of RNA polymerase III transcription during mammalian cell growth.

Authors:  Sarah J Goodfellow; Robert J White
Journal:  Cell Cycle       Date:  2007-10-20       Impact factor: 4.534

3.  TFIID can be rate limiting in vivo for TATA-containing, but not TATA-lacking, RNA polymerase II promoters.

Authors:  J Colgan; J L Manley
Journal:  Genes Dev       Date:  1992-02       Impact factor: 11.361

4.  RNA polymerase III transcription factor TFIIIC2 is overexpressed in ovarian tumors.

Authors:  A G Winter; G Sourvinos; S J Allison; K Tosh; P H Scott; D A Spandidos; R J White
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

5.  Transcriptional regulation of the TATA-binding protein by Ras cellular signaling.

Authors:  S A Johnson; N Mandavia; H D Wang; D L Johnson
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

6.  Regulation of RNA polymerase III transcription in response to Simian virus 40 transformation.

Authors:  R J White; D Stott; P W Rigby
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

7.  Mitotic repression of RNA polymerase III transcription in vitro mediated by phosphorylation of a TFIIIB component.

Authors:  J M Gottesfeld; V J Wolf; T Dang; D J Forbes; P Hartl
Journal:  Science       Date:  1994-01-07       Impact factor: 47.728

8.  The hepatitis B virus X protein increases the cellular level of TATA-binding protein, which mediates transactivation of RNA polymerase III genes.

Authors:  H D Wang; C H Yuh; C V Dang; D L Johnson
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

9.  Participation of cyclin A in Myc-induced apoptosis.

Authors:  A T Hoang; K J Cohen; J F Barrett; D A Bergstrom; C V Dang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

10.  Neoplastic transformation by the human gene N-myc.

Authors:  M B Small; N Hay; M Schwab; J M Bishop
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

View more
  75 in total

1.  Mechanisms of regulation of RNA polymerase III-dependent transcription by TORC1.

Authors:  Yuehua Wei; Chi Kwan Tsang; X F Steven Zheng
Journal:  EMBO J       Date:  2009-07-02       Impact factor: 11.598

2.  Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis.

Authors:  Alexandre Huber; Bernd Bodenmiller; Aino Uotila; Michael Stahl; Stefanie Wanka; Bertran Gerrits; Ruedi Aebersold; Robbie Loewith
Journal:  Genes Dev       Date:  2009-08-15       Impact factor: 11.361

Review 3.  Transcription by RNA polymerase III: more complex than we thought.

Authors:  Robert J White
Journal:  Nat Rev Genet       Date:  2011-05-04       Impact factor: 53.242

4.  Genome stability control by checkpoint regulation of tRNA gene transcription.

Authors:  Brett W Clelland; Michael C Schultz
Journal:  Transcription       Date:  2010-09-23

5.  Regulation of TFIIIB during F9 cell differentiation.

Authors:  Dimitris Athineos; Lynne Marshall; Robert J White
Journal:  BMC Mol Biol       Date:  2010-03-12       Impact factor: 2.946

6.  Alcohol-associated cancer and deregulation of Pol III genes.

Authors:  Ganggang Shi; Shuping Zhong
Journal:  Gene       Date:  2016-09-30       Impact factor: 3.688

7.  Elk1 and AP-1 sites in the TBP promoter mediate alcohol-induced deregulation of Pol III-dependent genes.

Authors:  Qian Zhong; Ganggang Shi; Yanmei Zhang; Daniel Levy; Shuping Zhong
Journal:  Gene       Date:  2013-02-20       Impact factor: 3.688

Review 8.  RNA polymerase III repression by the retinoblastoma tumor suppressor protein.

Authors:  Alison Gjidoda; R William Henry
Journal:  Biochim Biophys Acta       Date:  2012-10-12

Review 9.  Dysregulation of the basal RNA polymerase transcription apparatus in cancer.

Authors:  Megan J Bywater; Richard B Pearson; Grant A McArthur; Ross D Hannan
Journal:  Nat Rev Cancer       Date:  2013-05       Impact factor: 60.716

10.  Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors.

Authors:  Thomas J Owen; John D O'Neil; Christopher W Dawson; Chunfang Hu; Xiaoyi Chen; Yunhong Yao; Victoria H J Wood; Louise E Mitchell; Robert J White; Lawrence S Young; John R Arrand
Journal:  Mol Cancer       Date:  2010-09-15       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.